StockData
Eton Pharmaceuticals, Inc. logo

Eton Pharmaceuticals, Inc. (ETON) stock

ETONNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30524% above fair value
$63.65−0.23 (-0.36%)

Close on Nov 17, 2026Market cap $1.82BP/E 163.2Yield –

Eton Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Eton Pharmaceuticals's pe ratio was 175.4× on Nov 11, 2026.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 2026175.4×+85.4
2024Jul 31, 202490.0×+46.2
2023Dec 29, 202343.8×–

More Eton Pharmaceuticals figures

See a number that looks wrong?